Viewpoints on FDA: Enforcement

Posted on October 2009 by FDLI

Viewpoints on FDA: Enforcementis an invaluable resource for attorneys, manufacturers, consultants and other food and drug stakeholders, who want to know what FDA will be doing in the enforcement more

A tough question - but one that FDA, pharmaceutical manufacturers, physicians, patients and the courts now are urgently trying to answer. FDA has proposed rules that will make it easier for dying more

Second in a series of discussion on should terminally ill patients get access to unapproved drugs? Now Available Full Transcript from FDLI’s Colloquium #2, From Abigail to Penelope: more